Recent advances in metal-organic framework-based nanozymes for cancer theranostics driven by synthetic innovation and machine learning design
Colloids and Surfaces B: Biointerfaces · 2026
DOI: 10.1016/j.colsurfb.2026.115463 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Colloids and Surfaces B: Biointerfaces, 2026. Verfasst von Sangeeta Yadav und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Sciences, Indian Institute of Information Technology, Allahabad, UP 211015, India. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Neoplasms, Machine Learning, Theranostic Nanomedicine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 123 Literaturangaben. Gefördert von: Defence Science and Technology Group, Department of Science and Technology.
Abstract (Originalsprache)
Nanozymes are engineered nanomaterials designed at the atomic scale to fine-tune their structure, composition, and electronic properties, thereby creating active sites that mimic those of natural enzymes. Among these materials, Metal-organic frameworks (MOFs) are notable for their well-defined, porous frameworks, which are created by connecting metal ions or clusters with organic linkers. Their large surface area, adjustable porosity, and superior biocompatibility enable excellent catalytic activity. By containing specific catalytic functionalities, MOF-based nanozymes can mimic peroxidase, oxidase, catalase, and superoxide dismutase activities. These properties make them genuinely promising for biomedical applications, particularly in cancer diagnosis and therapy. Recent progress in synthetic design, post-synthetic modification, and machine learning-assisted optimization has enhanced their structural precision and catalytic efficiency. Furthermore, MOFs serve as multifunctional therapeutic platforms capable of supporting combined treatment strategies and producing synergistic therapeutic effects, thereby establishing their potential as next-generation systems for targeted cancer treatment and diagnostic integration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Sciences, Indian Institute of Information Technology, Allahabad, UP 211015, India.
- Post-Graduate and Research Department of Biotechnology, St. Xavier's College (Autonomous), Kolkata -700016, West Bengal, India.
- Department of Applied Sciences, Indian Institute of Information Technology, Allahabad, UP 211015, India; Department of Microrobotics, National Institute of Animal Biotechnology, Hyderabad, Telangana 500032, India.
- Department of Applied Sciences, Indian Institute of Information Technology, Allahabad, UP 211015, India. Electronic address: prf.ankita@iiita.ac.in.
- Department of Applied Sciences, Indian Institute of Information Technology, Allahabad, UP 211015, India. Electronic address: samantasintu@iiita.ac.in.
- Department of Applied Sciences, Indian Institute of Information Technology, Allahabad, UP 211015, India. Electronic address: asahoo@iiita.ac.in.
Förderung
- Defence Science and Technology Group
- Department of Science and Technology
Zitieren
APA
Yadav, S., Sarkar, A., Shivalkar, S., Fatima, F., Thakur, S. K., Chaudhary, A., Samanta, S. K., & Sahoo, A. K. (2026). Recent advances in metal-organic framework-based nanozymes for cancer theranostics driven by synthetic innovation and machine learning design. Colloids and Surfaces B: Biointerfaces. https://doi.org/10.1016/j.colsurfb.2026.115463
Vancouver
Yadav S, Sarkar A, Shivalkar S, Fatima F, Thakur SK, Chaudhary A, et al. Recent advances in metal-organic framework-based nanozymes for cancer theranostics driven by synthetic innovation and machine learning design. Colloids and Surfaces B: Biointerfaces. 2026. doi:10.1016/j.colsurfb.2026.115463
BibTeX
@article{Yadav2026,
author = {Yadav, Sangeeta and Sarkar, Aditi and Shivalkar, Saurabh and Fatima, Fiza and Thakur, Siddharth Kumar and Chaudhary, Ankita and Samanta, Sintu Kumar and Sahoo, Amaresh Kumar},
title = {Recent advances in metal-organic framework-based nanozymes for cancer theranostics driven by synthetic innovation and machine learning design},
journal = {Colloids and Surfaces B: Biointerfaces},
year = {2026},
doi = {10.1016/j.colsurfb.2026.115463}
}
EUVIMED